144 related articles for article (PubMed ID: 35901658)
1. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Jurmeister P; Schöler A; Arnold A; Klauschen F; Lenze D; Hummel M; Schweizer L; Bläker H; Pfitzner BM; Mamlouk S; Sers C; Denkert C; Stichel D; Frost N; Horst D; von Laffert M; Capper D
Mod Pathol; 2019 Jun; 32(6):855-865. PubMed ID: 30723296
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.
Zhao L; Huang S; Liu J; Zhao J; Li Q; Wang HQ
Medicine (Baltimore); 2017 Sep; 96(39):e8153. PubMed ID: 28953659
[TBL] [Abstract][Full Text] [Related]
5. Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma.
Liu Y; Lu T; Yuan M; Chen R; Lu J; Wang H; Wu Z; Wang Y
Lung Cancer; 2023 May; 179():107169. PubMed ID: 37003209
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Wang CX; Liu B; Wang YF; Zhang RS; Yu B; Lu ZF; Shi QL; Zhou XJ
Int J Clin Exp Pathol; 2014; 7(3):1266-74. PubMed ID: 24696747
[TBL] [Abstract][Full Text] [Related]
8. Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.
Xie M; Chen D; Li Y; Liu X; Kuang D; Li X
Diagn Pathol; 2022 Feb; 17(1):30. PubMed ID: 35172862
[TBL] [Abstract][Full Text] [Related]
9. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
Shukla S; Pandey RK; Husain N; Srivastava A
Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
[TBL] [Abstract][Full Text] [Related]
10. [Progress in pulmonary enteric adenocarcinoma].
Zuo Y; Bai H; Ying JM; Wang J
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):321-325. PubMed ID: 35448919
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma.
Todisco A; Internò V; Stucci LS; Ostuni C; Lovero D; D'Oronzo S; Mele F; Duda L; Palmirotta R; Silvestris F
Int J Biol Markers; 2019 Dec; 34(4):421-426. PubMed ID: 31556336
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Enteric Adenocarcinoma Harboring a BRAF G469V Mutation.
Shimizu D; Yamamoto H; Shien K; Taniguchi K; Miyoshi K; Namba K; Mesaki K; Sugimoto S; Soh J; Yamane M; Toyooka S
Acta Med Okayama; 2021 Dec; 75(6):759-762. PubMed ID: 34955547
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary enteric adenocarcinoma.
Gong J; Fan Y; Lu H
Transl Oncol; 2021 Aug; 14(8):101123. PubMed ID: 34000642
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary enteric adenocarcinoma: an overview.
Palmirotta R; Lovero D; D'Oronzo S; Todisco A; Internò V; Mele F; Stucci LS; Silvestris F
Expert Rev Mol Med; 2020 Apr; 22():e1. PubMed ID: 32340641
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma.
Liu K; Guo J; Liu K; Fan P; Zeng Y; Xu C; Zhong J; Li Q; Zhou Y
EBioMedicine; 2018 Oct; 36():196-208. PubMed ID: 30268834
[TBL] [Abstract][Full Text] [Related]
16. Low-Coverage Whole Genome Sequencing Using Laser Capture Microscopy with Combined Digital Droplet PCR: An Effective Tool to Study Copy Number and Kras Mutations in Early Lung Adenocarcinoma Development.
Mickler EA; Zhou H; Phang TL; Geraci MW; Stearman RS; Sears CR
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769463
[TBL] [Abstract][Full Text] [Related]
17. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
[TBL] [Abstract][Full Text] [Related]
18. Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma.
Smyth RJ; Thomas V; Fay J; Ryan R; Nicholson S; Morgan RK; Grogan L; Breathnach O; Morris PG; Toomey S; Hennessy BT; Furney SJ
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442412
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases.
Fassi E; Mandruzzato M; Zamparini M; Bianchi S; Petrelli F; Baggi A; Alberti A; Grisanti S; Berruti A
Lung Cancer; 2023 May; 179():107176. PubMed ID: 37015149
[TBL] [Abstract][Full Text] [Related]
20. Proteomics-Derived Biomarker Panel Facilitates Distinguishing Primary Lung Adenocarcinomas With Intestinal or Mucinous Differentiation From Lung Metastatic Colorectal Cancer.
Liu J; Chang X; Qian L; Chen S; Xue Z; Wu J; Luo D; Huang B; Fan J; Guo T; Nie X
Mol Cell Proteomics; 2024 Apr; 23(5):100766. PubMed ID: 38608841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
